HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Attenuation of corticotropin releasing factor-induced hypotension in anesthetized rats with the CRF antagonist, alpha-helical CRF9-41; comparison with effect on ACTH release.

Abstract
The effect of pretreatment with the corticotropin releasing factor (CRF-41) antagonist, alpha-helical CRF(9-41), on the hypotensive response obtained on peripheral administration of CRF-41 has been assessed in anesthetized Wistar rats. A single IV bolus dose of rat CRF-41 (2 nmol, at 0 min) produced a hypotensive effect which was rapid in onset (-52 mmHg at +1 min) and sustained throughout the 60-min study period (-42, -40, -26 and -16 mmHg at +3, +10, +30 and +60 min, respectively). The antagonist [alpha CRF(9-41)] was administered in consecutive bolus doses of 12.5, 25 and 50 nmol at -15, -10 and -5 min, respectively. This had no effect on mean arterial blood pressure (MABP) or heart rate, nor did it change significantly the magnitude of the initial rapid fall in MABP when CRF-41 was administered (-45 mmHg at +1 min). However, following pretreatment with alpha CRF(9-41), MABP returned to control values within 3 min and the sustained period of hypotension was completely blocked. Administration of CRF-41 resulted in 44% and 142% increases in norepinephrine and epinephrine measured at +60 min. Pretreatment with the antagonist attenuated the rise in circulating catecholamine levels observed after CRF-41 administration. In comparison, pretreatment with the antagonist did not alter the ACTH response to CRF-41 at +1 and +3 min and only reduced ACTH levels by 28% (p less than 0.05), 43% (p less than 0.001) and 41% (p less than 0.01) at 10, 30 and 60 min, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
AuthorsR Corder, D Turnill, N Ling, R C Gaillard
JournalPeptides (Peptides) 1992 Jan-Feb Vol. 13 Issue 1 Pg. 1-6 ISSN: 0196-9781 [Print] United States
PMID1320258 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Catecholamines
  • Neuropeptide Y
  • Peptide Fragments
  • Adrenocorticotropic Hormone
  • Corticotropin-Releasing Hormone
  • corticotropin releasing hormone (9-41)
Topics
  • Adrenocorticotropic Hormone (drug effects, metabolism)
  • Anesthesia, Intravenous
  • Animals
  • Blood Pressure Determination
  • Catecholamines (blood)
  • Cells, Cultured
  • Corticotropin-Releasing Hormone (antagonists & inhibitors, pharmacology)
  • Female
  • Hypotension (metabolism)
  • Neuropeptide Y (blood)
  • Peptide Fragments (pharmacology)
  • Pituitary Gland, Anterior (cytology, metabolism)
  • Protein Conformation
  • Rats

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: